EcoDrugPlus

Ensembl ID : TC032822
Gene Symbol: 664299
1 External references
147 Possible Orthologues:

Ensembl ID : TC032882
Gene Symbol: 663226
1 External references
435 Possible Orthologues:

Ensembl ID : TC033027
Gene Symbol: 659779
1 External references
258 Possible Orthologues:

Ensembl ID : TC033093
Gene Symbol: 662673
1 External references
119 Possible Orthologues:

Ensembl ID : TC033102
Gene Symbol: 103314938
1 External references
67 Possible Orthologues:

Ensembl ID : TC033631
Gene Symbol: 656696
1 External references
32 Possible Orthologues:

Ensembl ID : TC033773
Gene Symbol: 664058
1 External references
89 Possible Orthologues:

Ensembl ID : TC034177
Gene Symbol: 659601
1 External references
226 Possible Orthologues:

Ensembl ID : TC034198
Gene Symbol: 663643
1 External references
54 Possible Orthologues:

Ensembl ID : TC034253
Gene Symbol: 663002
1 External references
115 Possible Orthologues:

Ensembl ID : TC034298
Gene Symbol: 657044
1 External references
1477 Possible Orthologues:

Ensembl ID : TC034305
Gene Symbol: 657515
1 External references
340 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).